SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : ArQule -- Ignore unavailable to you. Want to Upgrade?

To: Herc who wrote (367)7/28/1999 5:07:00 PM
From: John Dwyer  Respond to of 399
 

You wrote:

So I did a little comparison of ARQL and SEPR. SEPR has a p/s of 153 and a p/bv of 209; ARQL has a p/s of 4.53 and a p/bv of 1.74.
____

But remember, SEPR should be quite profitable in
about 2-3 years while ARQL will require, what, at least
five. If you discount these cash flows back, even using
a rather high discount rate, SEPR is not that overvalued
in the 70's.


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News